Israeli medtech firm Nanox worth over $1.2b. with no revenue, FDA approval
Despite lacking approval or revenue, its share price has continued to soar. Read More JPost.com – Homepage
Despite lacking approval or revenue, its share price has continued to soar. Read More JPost.com – Homepage